Yu Miyazaki

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2

Yu Miyazaki, Hiroaki Adachi, Masahisa Katsuno et al. · Nature Medicine · 2012 · 151 citations

Life Sciences, Molecular Biology, Molecular Medicine +14

Identification and Characterization of GABAA Receptor Autoantibodies in Autoimmune Encephalitis

Toshika Ohkawa, Shin’Ichiro Satake, Norihiko Yokoi et al. · Journal of Neuroscience · 2014 · 128 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer

Takayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki et al. · Scientific Reports · 2019 · 74 citations · Full text

Medicine, Genetics, Oncology +17

An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the <i>CACNA1A</i> second cistron

Yu Miyazaki, Xiaofei Du, Shin‐ichi Muramatsu et al. · Science Translational Medicine · 2016 · 73 citations · Full text

Life Sciences, Molecular Biology, Neurology +16